Subscribe to Newsletter

Small Molecules

Business & Regulation Business Practice

Calling Out Misleading Information

| Rob Coker | 2 min read

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

Manufacture Technology and Equipment

The Myths and Reality of Hot Melt Extrusion

| Hibreniguss Terefe, Shahab Kashani Rahimi | 6 min read

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

Business & Regulation Standards & Regulation

GSK’s Flovent Strategy Under Federal Scrutiny?

| Rob Coker | 2 min read

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Discovery & Development Dosage Forms

Co-Crystals Shine in Innovation Awards

| 1 min read

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

Business & Regulation Standards & Regulation

AMF’s 2026 AMR Strategy, Revealed

| Rob Coker | 3 min read

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Discovery & Development Dosage Forms

Three Trends to Watch in Oral Solid Dosages

| Jennifer Gattari | 4 min read

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

Discovery & Development Drug Discovery

Examining the Effectiveness of Antidepressants

| Stephanie Vine | 2 min read

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

Manufacture Small Molecules

2025 Predictions for RNA Therapeutics

| Kate Broderick | 5 min read

So much has already been achieved with RNA – and it’s only going to get better.

Business & Regulation Trends & Forecasts

mRNA Trend Setters

| 2 min read

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.

Business & Regulation Standards & Regulation

Settling the PrEP Patent Disputes

| Rob Coker | 2 min read

With US courts consistently ruling in favor of the PrEP drug manufacture, the CDC and DHHS have had no choice but to be humble.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register